Please enable JavaScript.  This webapp requires JavaScript to work at its best.

All Resources

Use this page to search through all of our online resources available in our Neurology and Oncology therapy areas.

Lenvima (lenvatinib) HCC

Optimising Care – Ian Chau case study

VIEW RESOURCE
Lenvima (lenvatinib) DTC

Welcome to iCases – Dr Brammer

VIEW RESOURCE
Lenvima (lenvatinib) HCC

Talking HEDs – HCC, Experts & Data. Podcast: Episode 2

VIEW RESOURCE
Lenvima (lenvatinib) DTC

First Thoughts Bitecast Webninar 30th November 2022 On Demand

VIEW RESOURCE
Halaven (eribulin)

First Thoughts Breast Cancer Bitecast 27th Feb 2023 – On Demand

VIEW RESOURCE
Lenvima (lenvatinib) DTC

ETA 2022 Satellite symposium

VIEW RESOURCE
Lenvima (lenvatinib) HCC

Patient Conversations in uHCC

VIEW RESOURCE
Halaven (eribulin)

First Thoughts Breast Cancer Bitecast
21st Sept 2022 On Demand

VIEW RESOURCE
Kisplyx (lenvatinib)

KISPLYX AE management guide

VIEW RESOURCE
Lenvima (lenvatinib) HCC

Talking HEDs – HCC, Experts & Data. Podcast: Episode 1

VIEW RESOURCE
Lenvima (lenvatinib) DTC

First Thoughts Bitecast Webinar – Dr Kate Garcez

VIEW RESOURCE
Lenvima (lenvatinib) HCC

Optimising care – Sarah Selemani case study

VIEW RESOURCE
Halaven (eribulin)

First Thoughts Breast Cancer Bitecast 21st June 2022 On Demand

VIEW RESOURCE
Kisplyx (lenvatinib)

Patient case study: Dr Prantik Das

VIEW RESOURCE
Halaven (eribulin)

First Thoughts Breast Cancer Bitecast May 2022
On Demand

VIEW RESOURCE
Kisplyx (lenvatinib)

Renal Cell Carcinoma (RCC) First Thoughts Meeting 2021 Newsletter

VIEW RESOURCE
Kisplyx (lenvatinib)

Renal Cell Carcinoma (RCC) First Thoughts Meeting 2021 On Demand

VIEW RESOURCE
Lenvima (lenvatinib) HCC

Patient guide and treatment diary

VIEW RESOURCE
Lenvima (lenvatinib) DTC

Patient guide and treatment diary

VIEW RESOURCE
Lenvima (lenvatinib) DTC

AE monitoring & management guide

VIEW RESOURCE
Halaven (eribulin)

Patient Information Leaflet

VIEW RESOURCE
Halaven (eribulin)

Dosing & Administration Guide

VIEW RESOURCE
Halaven (eribulin)

EMPOWER Study Summary

VIEW RESOURCE
Lenvima (lenvatinib) DTC

Dosing & administration guide

VIEW RESOURCE
Lenvima (lenvatinib) HCC

Patient Case study: CV Comorbidities

VIEW RESOURCE
Lenvima (lenvatinib) HCC

REFLECT study overview

VIEW RESOURCE
Lenvima (lenvatinib) HCC

Case Example: Managing AEs with Dose Adjustment

VIEW RESOURCE
Halaven (eribulin)

Halaven at Home

VIEW RESOURCE
Fycompa (perampanel)

Adult and Adolescent dosage guide

VIEW RESOURCE
Inovelon (rufinamide)

Inovelon Dosage Guide

VIEW RESOURCE
Halaven (eribulin)

Adverse Event Monitoring and Management Guide

VIEW RESOURCE
Lenvima (lenvatinib) DTC

Professor Marcia Brose Webinar

VIEW RESOURCE
Lenvima (lenvatinib) DTC

Patient Case Study Prof Jon Wadsley

VIEW RESOURCE
Lenvima (lenvatinib) DTC

Patient Case Study Dr Vanessa Gill

VIEW RESOURCE
Lenvima (lenvatinib) EC

AE Management Guide

VIEW RESOURCE
Lenvima (lenvatinib) EC

Dosing Guide

VIEW RESOURCE
Keytruda (pembrolizumab)+ Kisplyx (lenvatinib)

Keytruda + Kisplyx Treatment Optimisation Guide

VIEW RESOURCE